Tumor aggressiveness determined by tissue environment, says trial

11 December 2006

New research carried out at the University of Dundee in Scotland suggests that the aggressiveness of cancerous tumors may be determined by the tissue environment in which they develop. The study, which was carried out by Sandy Anderson of the university's department of mathematics, was published in the December 1 edition of the scientific journal, Cell.

Dr Anderson developed a complex mathematical model that is capable of predicting tumor growth and proliferation. Subsequent analysis revealed that the shape of tumors, in addition to their environment, is a key indicator of aggression. Specifically, the work showed that more aggressive tumors adopt a "spidery-shape" whereas benign growths were generally spherical in conformation.

Dr Anderson explained that the findings were "important in terms of the surgical removal of tumors," and added that "a model like this could help predict how tumors will grow in different tissue environments, ie, different areas of the body, and what the best strategy may be to treat them."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight